Chiral ionic Liquid-based Vortex-assisted Enantio-separation of S-(+) and R-(-) Besifloxacin and Evaluation of Zeropoint Energy by Two-phase Liquid-liquid Extraction

Author:

Shankar Eegala Bheema1ORCID,Naidu Challa Gangu2ORCID,Devaraju Subramani1,Rao K Varaprasada3,Ramachandra Bondigalla4,Rao Y. Srinivasa3ORCID,Marok Satwinder S5

Affiliation:

1. 1Division of Chemistry, Department of Science and Humanities, Vignan's Foundation for Science, Technology and Research (Deemed to be University) VFSTRU, Vadlamudi, Guntur, Andhra Pradesh 522213, India.

2. 2Department of Basic Sciences and Humanities (B S&H), Vignan’s Institute of Information Technology (VIIT), Besides VSEZ, Vadlapudi Duvvada, Visakhapatnam, Andhra Pradesh, 530049 India.

3. 4Department of Pharmaceutics, Vignan Institute of Pharmaceutical Technology (VIPT), Besides VSEZ, Vadlapudi Duvvada, Visakhapatnam, Andhra Pradesh, 530049 India.

4. 3Government College for Men, Andhra Pradesh, Kadapa, 516004 India.

5. 5Apotex Inc, 150 Signet Drive, Toronto, ON, M9L1T9. Canada.

Abstract

Besifloxacin is a fourth-generation fluoroquinolone and shows significant antibacterial properties, which works well against a range of bacteria. Besifloxacin ophthalmic solution is the name of the specific form of this medication used to treat eye infections. The vortex-assisted chiral ionic liquid method was used for the separation of Besifloxacin isomers. S- Besifloxacin shows antibacterial action in clinical trials. The R-isomer, however, has not shown biological properties in clinical testing through different cell line. The current proposed chiral assay method was developed between a racemic mixture and a chiral selector. The analytical databases affirm that 1, 2 dichloroethane is used as a non-aqueous (organic media) solvent and that 1,3-butyl-3-methylimidazole L-tryptophan ([Bmim] [Ltrp]) opted used as a specific chiral ionic liquid. The developed ionic liquid based chital hplc method was successfully applied to separation and purification of isomers of Besifloxacin in during the process industries in bulk drugs.

Publisher

Oriental Scientific Publishing Company

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3